Medtronic MiniMed recalled 13,811 MiniMed 700G insulin pumps sold worldwide through multiple retailers. The pumps can deliver too much or too little insulin when the pump height relative to the infusion site changes due to gravity. Consumers should stop using the device and follow recall instructions in the letter notice sent to affected users.
Quick Facts at a Glance
Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The MiniMed 700G is an insulin pump used by people with diabetes to deliver continuous insulin therapy via a small catheter. It is designed to automate insulin delivery and often integrates with glucose monitoring software.
Why This Is Dangerous
The device’s insulin delivery depends on gravity. Elevation or lowering of the pump relative to the infusion site changes hydrostatic pressure, potentially delivering too much or too little insulin.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
For patients relying on the pump, the recall creates urgent safety concerns. The potential for life-threatening hypoglycemia or diabetic ketoacidosis requires immediate action and coordination with healthcare providers.
Practical Guidance
How to identify if yours is affected
Locate the model number on the device label (MMT-1801, MMT-1805, MMT-1850, MMT-1851).
Compare the model number to the recall list provided by Medtronic and the FDA notice.
Check for recall notification letters or communications from Medtronic MiniMed.
Where to find product info
Refer to the FDA recall page and Medtronic MiniMed recall communications. The recall notice includes model numbers and remedy instructions. The enforcement page URL is in the article.
What timeline to expect
Refunds or replacements are typically processed within a matter of weeks after confirmation of eligible devices. Expect several weeks for remedies to
If the manufacturer is unresponsive
Document all outreach attempts to Medtronic MiniMed.
Escalate to the FDA recall program or relevant consumer protection agency if the company is unresponsive.
Consider seeking guidance from your healthcare provider.
How to prevent similar issues
Avoid using recalled pumps and monitor for symptoms of hypo- or hyperglycemia.
When buying new pumps, verify model numbers and confirm recall status before use.
Register medical devices with the manufacturer to receive updates.
Documentation advice
Keep the recall notice, any letters received, device serial/model numbers, purchase records, and correspondence with the manufacturer as part of your records.
Product Details
Product: MiniMed 700G Insulin Pump. Models: MMT-1801, MMT-1805, MMT-1850, MMT-1851. Sold worldwide, including all US states listed in recall distribution. Recall date: 2026-02-13. Report date: 2026-04-08. Quantity recalled: 13,811 units. Manufacturer: Medtronic MiniMed, Inc. Country of origin: Unknown. Price: Unknown.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
13,811 units recalled
Models MMT-1801, MMT-1805, MMT-1850, MMT-1851
Recall Date 2026-02-13
Report Date 2026-04-08
Hazard: unintended insulin delivery due to pump height changes
Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s
Medtronic recalled 13,429 MiniMed insulin pumps worldwide after identifying unintended insulin delivery errors. The issue occurs when the pump height relative to the infusion site changes, causing over-delivery or under-delivery of insulin. Patients should stop using the device and contact Medtronic for instructions.
Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap
Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,
Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the
Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.
Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.
Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.